Albuminuria, lung function decline, and risk of incident chronic obstructive pulmonary disease the NHLBI pooled cohorts study

Elizabeth C. Oelsner, Pallavi P. Balte, Morgan E. Grams, Patricia A. Cassano, David R Jacobs Jr, R. Graham Barr, Kristin M. Burkart, Ravi Kalhan, Richard Kronmal, Laura R. Loehr, George T. O’Connor, Joseph E. Schwartz, Michael Shlipak, Russell P. Tracy, Michael Y Tsai, Wendy White, Sachin Yende

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Rationale: Chronic lower respiratory diseases (CLRDs), including chronic obstructive pulmonary disease (COPD) and asthma, are the fourth leading cause of death. Prior studies suggest that albuminuria, a biomarker of endothelial injury, is increased in patients with COPD. Objectives: To test whether albuminuria was associated with lung function decline and incident CLRDs. Methods: Six U.S. population–based cohorts were harmonized and pooled. Participants with prevalent clinical lung disease were excluded. Albuminuria (urine albumin-to-creatinine ratio) was measured in spot samples. Lung function was assessed by spirometry. Incident CLRD-related hospitalizations and deaths were classified via adjudication and/or administrative criteria. Mixed and proportional hazards models were used to test individual-level associations adjusted for age, height, weight, sex, race/ethnicity, education, birth year, cohort, smoking status, pack-years of smoking, renal function, hypertension, diabetes, and medications. Measurements and Main Results: Among 10,961 participants with preserved lung function, mean age at albuminuria measurement was 60 years, 51% were never-smokers, median albuminuria was 5.6 mg/g, and mean FEV 1 decline was 31.5 ml/yr. For each SD increase in log-transformed albuminuria, there was 2.81% greater FEV 1 decline (95% confidence interval [CI], 0.86–4.76%; P = 0.0047), 11.02% greater FEV 1 /FVC decline (95% CI, 4.43–17.62%; P = 0.0011), and 15% increased hazard of incident spirometry-defined moderate-to-severe COPD (95% CI, 2–31%, P = 0.0021). Each SD log-transformed albuminuria increased hazards of incident COPD-related hospitalization/mortality by 26% (95% CI, 18–34%, P, 0.0001) among 14,213 participants followed for events. Asthma events were not significantly associated. Associations persisted in participants without current smoking, diabetes, hypertension, or cardiovascular disease. Conclusions: Albuminuria was associated with greater lung function decline, incident spirometry-defined COPD, and incident COPD-related events in a U.S. population–based sample.

Original languageEnglish (US)
Pages (from-to)321-332
Number of pages12
JournalAmerican journal of respiratory and critical care medicine
Volume199
Issue number3
DOIs
StatePublished - Feb 1 2019

Fingerprint

National Heart, Lung, and Blood Institute (U.S.)
Albuminuria
Chronic Obstructive Pulmonary Disease
Cohort Studies
Lung
Spirometry
Confidence Intervals
Smoking
Hospitalization
Asthma
Renal Hypertension
Proportional Hazards Models
Lung Diseases
Cause of Death
Albumins
Creatinine
Cardiovascular Diseases
Biomarkers
Urine
Parturition

Keywords

  • Asthma
  • Epidemiology
  • Spirometry

PubMed: MeSH publication types

  • Journal Article

Cite this

Albuminuria, lung function decline, and risk of incident chronic obstructive pulmonary disease the NHLBI pooled cohorts study. / Oelsner, Elizabeth C.; Balte, Pallavi P.; Grams, Morgan E.; Cassano, Patricia A.; Jacobs Jr, David R; Graham Barr, R.; Burkart, Kristin M.; Kalhan, Ravi; Kronmal, Richard; Loehr, Laura R.; O’Connor, George T.; Schwartz, Joseph E.; Shlipak, Michael; Tracy, Russell P.; Tsai, Michael Y; White, Wendy; Yende, Sachin.

In: American journal of respiratory and critical care medicine, Vol. 199, No. 3, 01.02.2019, p. 321-332.

Research output: Contribution to journalArticle

Oelsner, EC, Balte, PP, Grams, ME, Cassano, PA, Jacobs Jr, DR, Graham Barr, R, Burkart, KM, Kalhan, R, Kronmal, R, Loehr, LR, O’Connor, GT, Schwartz, JE, Shlipak, M, Tracy, RP, Tsai, MY, White, W & Yende, S 2019, 'Albuminuria, lung function decline, and risk of incident chronic obstructive pulmonary disease the NHLBI pooled cohorts study', American journal of respiratory and critical care medicine, vol. 199, no. 3, pp. 321-332. https://doi.org/10.1164/rccm.201803-0402OC
Oelsner, Elizabeth C. ; Balte, Pallavi P. ; Grams, Morgan E. ; Cassano, Patricia A. ; Jacobs Jr, David R ; Graham Barr, R. ; Burkart, Kristin M. ; Kalhan, Ravi ; Kronmal, Richard ; Loehr, Laura R. ; O’Connor, George T. ; Schwartz, Joseph E. ; Shlipak, Michael ; Tracy, Russell P. ; Tsai, Michael Y ; White, Wendy ; Yende, Sachin. / Albuminuria, lung function decline, and risk of incident chronic obstructive pulmonary disease the NHLBI pooled cohorts study. In: American journal of respiratory and critical care medicine. 2019 ; Vol. 199, No. 3. pp. 321-332.
@article{9a92a82b8baf457e81ce6f5cdbb16fe7,
title = "Albuminuria, lung function decline, and risk of incident chronic obstructive pulmonary disease the NHLBI pooled cohorts study",
abstract = "Rationale: Chronic lower respiratory diseases (CLRDs), including chronic obstructive pulmonary disease (COPD) and asthma, are the fourth leading cause of death. Prior studies suggest that albuminuria, a biomarker of endothelial injury, is increased in patients with COPD. Objectives: To test whether albuminuria was associated with lung function decline and incident CLRDs. Methods: Six U.S. population–based cohorts were harmonized and pooled. Participants with prevalent clinical lung disease were excluded. Albuminuria (urine albumin-to-creatinine ratio) was measured in spot samples. Lung function was assessed by spirometry. Incident CLRD-related hospitalizations and deaths were classified via adjudication and/or administrative criteria. Mixed and proportional hazards models were used to test individual-level associations adjusted for age, height, weight, sex, race/ethnicity, education, birth year, cohort, smoking status, pack-years of smoking, renal function, hypertension, diabetes, and medications. Measurements and Main Results: Among 10,961 participants with preserved lung function, mean age at albuminuria measurement was 60 years, 51{\%} were never-smokers, median albuminuria was 5.6 mg/g, and mean FEV 1 decline was 31.5 ml/yr. For each SD increase in log-transformed albuminuria, there was 2.81{\%} greater FEV 1 decline (95{\%} confidence interval [CI], 0.86–4.76{\%}; P = 0.0047), 11.02{\%} greater FEV 1 /FVC decline (95{\%} CI, 4.43–17.62{\%}; P = 0.0011), and 15{\%} increased hazard of incident spirometry-defined moderate-to-severe COPD (95{\%} CI, 2–31{\%}, P = 0.0021). Each SD log-transformed albuminuria increased hazards of incident COPD-related hospitalization/mortality by 26{\%} (95{\%} CI, 18–34{\%}, P, 0.0001) among 14,213 participants followed for events. Asthma events were not significantly associated. Associations persisted in participants without current smoking, diabetes, hypertension, or cardiovascular disease. Conclusions: Albuminuria was associated with greater lung function decline, incident spirometry-defined COPD, and incident COPD-related events in a U.S. population–based sample.",
keywords = "Asthma, Epidemiology, Spirometry",
author = "Oelsner, {Elizabeth C.} and Balte, {Pallavi P.} and Grams, {Morgan E.} and Cassano, {Patricia A.} and {Jacobs Jr}, {David R} and {Graham Barr}, R. and Burkart, {Kristin M.} and Ravi Kalhan and Richard Kronmal and Loehr, {Laura R.} and O’Connor, {George T.} and Schwartz, {Joseph E.} and Michael Shlipak and Tracy, {Russell P.} and Tsai, {Michael Y} and Wendy White and Sachin Yende",
year = "2019",
month = "2",
day = "1",
doi = "10.1164/rccm.201803-0402OC",
language = "English (US)",
volume = "199",
pages = "321--332",
journal = "American Journal of Respiratory and Critical Care Medicine",
issn = "1073-449X",
publisher = "American Thoracic Society",
number = "3",

}

TY - JOUR

T1 - Albuminuria, lung function decline, and risk of incident chronic obstructive pulmonary disease the NHLBI pooled cohorts study

AU - Oelsner, Elizabeth C.

AU - Balte, Pallavi P.

AU - Grams, Morgan E.

AU - Cassano, Patricia A.

AU - Jacobs Jr, David R

AU - Graham Barr, R.

AU - Burkart, Kristin M.

AU - Kalhan, Ravi

AU - Kronmal, Richard

AU - Loehr, Laura R.

AU - O’Connor, George T.

AU - Schwartz, Joseph E.

AU - Shlipak, Michael

AU - Tracy, Russell P.

AU - Tsai, Michael Y

AU - White, Wendy

AU - Yende, Sachin

PY - 2019/2/1

Y1 - 2019/2/1

N2 - Rationale: Chronic lower respiratory diseases (CLRDs), including chronic obstructive pulmonary disease (COPD) and asthma, are the fourth leading cause of death. Prior studies suggest that albuminuria, a biomarker of endothelial injury, is increased in patients with COPD. Objectives: To test whether albuminuria was associated with lung function decline and incident CLRDs. Methods: Six U.S. population–based cohorts were harmonized and pooled. Participants with prevalent clinical lung disease were excluded. Albuminuria (urine albumin-to-creatinine ratio) was measured in spot samples. Lung function was assessed by spirometry. Incident CLRD-related hospitalizations and deaths were classified via adjudication and/or administrative criteria. Mixed and proportional hazards models were used to test individual-level associations adjusted for age, height, weight, sex, race/ethnicity, education, birth year, cohort, smoking status, pack-years of smoking, renal function, hypertension, diabetes, and medications. Measurements and Main Results: Among 10,961 participants with preserved lung function, mean age at albuminuria measurement was 60 years, 51% were never-smokers, median albuminuria was 5.6 mg/g, and mean FEV 1 decline was 31.5 ml/yr. For each SD increase in log-transformed albuminuria, there was 2.81% greater FEV 1 decline (95% confidence interval [CI], 0.86–4.76%; P = 0.0047), 11.02% greater FEV 1 /FVC decline (95% CI, 4.43–17.62%; P = 0.0011), and 15% increased hazard of incident spirometry-defined moderate-to-severe COPD (95% CI, 2–31%, P = 0.0021). Each SD log-transformed albuminuria increased hazards of incident COPD-related hospitalization/mortality by 26% (95% CI, 18–34%, P, 0.0001) among 14,213 participants followed for events. Asthma events were not significantly associated. Associations persisted in participants without current smoking, diabetes, hypertension, or cardiovascular disease. Conclusions: Albuminuria was associated with greater lung function decline, incident spirometry-defined COPD, and incident COPD-related events in a U.S. population–based sample.

AB - Rationale: Chronic lower respiratory diseases (CLRDs), including chronic obstructive pulmonary disease (COPD) and asthma, are the fourth leading cause of death. Prior studies suggest that albuminuria, a biomarker of endothelial injury, is increased in patients with COPD. Objectives: To test whether albuminuria was associated with lung function decline and incident CLRDs. Methods: Six U.S. population–based cohorts were harmonized and pooled. Participants with prevalent clinical lung disease were excluded. Albuminuria (urine albumin-to-creatinine ratio) was measured in spot samples. Lung function was assessed by spirometry. Incident CLRD-related hospitalizations and deaths were classified via adjudication and/or administrative criteria. Mixed and proportional hazards models were used to test individual-level associations adjusted for age, height, weight, sex, race/ethnicity, education, birth year, cohort, smoking status, pack-years of smoking, renal function, hypertension, diabetes, and medications. Measurements and Main Results: Among 10,961 participants with preserved lung function, mean age at albuminuria measurement was 60 years, 51% were never-smokers, median albuminuria was 5.6 mg/g, and mean FEV 1 decline was 31.5 ml/yr. For each SD increase in log-transformed albuminuria, there was 2.81% greater FEV 1 decline (95% confidence interval [CI], 0.86–4.76%; P = 0.0047), 11.02% greater FEV 1 /FVC decline (95% CI, 4.43–17.62%; P = 0.0011), and 15% increased hazard of incident spirometry-defined moderate-to-severe COPD (95% CI, 2–31%, P = 0.0021). Each SD log-transformed albuminuria increased hazards of incident COPD-related hospitalization/mortality by 26% (95% CI, 18–34%, P, 0.0001) among 14,213 participants followed for events. Asthma events were not significantly associated. Associations persisted in participants without current smoking, diabetes, hypertension, or cardiovascular disease. Conclusions: Albuminuria was associated with greater lung function decline, incident spirometry-defined COPD, and incident COPD-related events in a U.S. population–based sample.

KW - Asthma

KW - Epidemiology

KW - Spirometry

UR - http://www.scopus.com/inward/record.url?scp=85060930154&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85060930154&partnerID=8YFLogxK

U2 - 10.1164/rccm.201803-0402OC

DO - 10.1164/rccm.201803-0402OC

M3 - Article

VL - 199

SP - 321

EP - 332

JO - American Journal of Respiratory and Critical Care Medicine

JF - American Journal of Respiratory and Critical Care Medicine

SN - 1073-449X

IS - 3

ER -